Please use this identifier to cite or link to this item:
https://www.arca.fiocruz.br/handle/icict/35668
Type
ArticleCopyright
Open access
Collections
- IOC - Artigos de Periódicos [12978]
Metadata
Show full item record
IMPACT OF ANTIBIOTIC RESISTANCE ON OUTCOMES OF NEUTROPENIC CANCER PATIENTS WITH PSEUDOMONAS AERUGINOSA BACTERAEMIA (IRONIC STUDY): STUDY PROTOCOL OF A RETROSPECTIVE MULTICENTRE INTERNATIONAL STUDY
Estudo internacional multicêntrico
Protocolo de estudo
Pacientes com câncer neutropênico
Retrospectiva
Bacteremia por Pseudomonas aeruginosa
Neutropenic cancer patients
Pseudomonas aeruginosa bacteraemia
Study protocol
Multicentre international study
Retrospective
Author
Albasanz-Puig, Adaia
Gudiol, Carlota
Parody, Rocío
Tebe, Cristian
Akova, Murat
Araos, Rafael
Bote, Anna
Brunel, Anne-Sophie
Calik, Sebnem
Drgona, Lubos
García, Estefanía
Hemmati, Philipp
Herrera, Fabián
Ibrahim, Karim Yaqub
Isler, Burcu
Kanj, Souha
Kern, Winfried
Maestro de la Calle, Guillermo
Manzur, Adriana
Marin, Jorge Iván
Márquez-Gómez, Ignacio
Martín-Dávila, Pilar
Mikulska, Malgorzata
Montejo, José Miguel
Montero, Milagros
Morales, Hugo Manuel Paz
Morales, Isabel
Novo, Andrés
Oltolini, Chiara
Peghin, Maddalena
Del Pozo, Jose Luis
Puerta-Alcalde, Pedro
Ruiz-Camps, Isabel
Sipahi, Oguz Resat
Tilley, Robert
Yáñez, Lucrecia
Gomes, Marisa Zenaide Ribeiro
Carratalà, Jordi
Gudiol, Carlota
Parody, Rocío
Tebe, Cristian
Akova, Murat
Araos, Rafael
Bote, Anna
Brunel, Anne-Sophie
Calik, Sebnem
Drgona, Lubos
García, Estefanía
Hemmati, Philipp
Herrera, Fabián
Ibrahim, Karim Yaqub
Isler, Burcu
Kanj, Souha
Kern, Winfried
Maestro de la Calle, Guillermo
Manzur, Adriana
Marin, Jorge Iván
Márquez-Gómez, Ignacio
Martín-Dávila, Pilar
Mikulska, Malgorzata
Montejo, José Miguel
Montero, Milagros
Morales, Hugo Manuel Paz
Morales, Isabel
Novo, Andrés
Oltolini, Chiara
Peghin, Maddalena
Del Pozo, Jose Luis
Puerta-Alcalde, Pedro
Ruiz-Camps, Isabel
Sipahi, Oguz Resat
Tilley, Robert
Yáñez, Lucrecia
Gomes, Marisa Zenaide Ribeiro
Carratalà, Jordi
Affilliation
Infectious Diseases Department. Bellvitge University Hospital. IDIBELL. University of Barcelona. Barcelona, Spain / Spanish Network for Research in Infectious Diseases (REIPI). Instituto de Salud Carlos III. Madrid, Spain.
Infectious Diseases Department. Bellvitge University Hospital. IDIBELL. University of Barcelona. Barcelona, Spain / Spanish Network for Research in Infectious Diseases (REIPI). Instituto de Salud Carlos III. Madrid, Spain.
Haematology Department, Institut Català d' Oncologia (ICO). Hospital Duran i Reynals, IDIBELL, Barcelona, Spain.
Statistics Advisory Service, Institute of Biomedical Research of Bellvitge, Rovira i Virgili University. Barcelona, Spain.
Infectious Diseases Department, Hacettepe University School of Medicine. Ankara, Turkey.
Infectious Diseases Department, Instituto de Ciencias e Innovación en Medicina, Facultad de Medicina, Clínica Alemana. Universidad del Desarrollo, Santiago de Chile, Chile.
Infectious Diseases Department. Parc Taulí University Hospital, Sabadell, Barcelona, Spain.
Infectious Diseases Department, Department of Medicine, Lausanne University Hospital (CHUV). Lausanne, Switzerland.
Department of Infectious Diseases and Clinical Microbiology, University of Health Science Izmir Bozyaka Training and Research Hospital, Izmir, Turkey.
Oncohematology Department, Comenius University and National Cancer Institute. Bratislava, Slovakia.
Haematology Department, Reina Sofía University Hospital-IMIBIC-UCO. Córdoba, Spain.
Department of Haematology, Oncology and Palliative Care, Klinikum Ernst von Bergmann, Academic Teaching Hospital of Charité University Medical School, Berlin, Germany.
Centro de Educación Médica e Investigaciones Clínicas (CEMIC). Departament of Medicine, Infectious Disease Section. Buenos Aires, Argentina.
Universidade de São Paulo. Faculdade de Medicina. Instituto do Câncer do Estado de São Paulo. São Paulo, SP, Brasil.
Department of Infectious Diseases and Clinical Microbiology, Istanbul Education and Research Hospital. Istanbul, Turkey.
Infectious Diseases Division. American University of Beirut Medical Center. Beirut, Lebanon.
Division of Infectious Diseases, Department of Medicine II, University of Freiburg, Medical Center and Faculty of Medicine. Freiburg, Germany.
Infectious Diseases Unit, Instituto de Investigación Hospital "12 de Octubre" (i+12), " 12 de Octubre" University Hospital, School of Medicine, Universidad Complutense. Madrid, Spain.
Hospital Rawson. Infectious Diseases. San Juan, Argentina
Infectious Diseases and Clinical Microbiology Department, Clínica Maraya. Pereira, Colombia / Critical Care and Clinical Microbiology Department. Universidad de Manizales. Manizales, Colombia.
Hospital Regional Universitario de Málaga. Infectious Diseases Department. Málaga, Spain.
Ramon y Cajal Hospital, Madrid. Infectious Diseases Department. Madrid, Spain.
University of Genoa (DISSAL) and Ospedale Policlinico San Martino. Division of Infectious Diseases. Genova, Italy.
Spanish Network for Research in Infectious Diseases (REIPI). Instituto de Salud Carlos III. Madrid, Spain / Cruces University Hospital. Infectious Diseases Unit. Bilbao, Spain.
Spanish Network for Research in Infectious Diseases (REIPI). Instituto de Salud Carlos III. Madrid, Spain / Infectious Diseases Service, Hospital del Mar, Infectious Pathology and Antimicrobials Research Group (IPAR), Institut Hospital del Mar d'Investigacions Mèdiques (IMIM), Universitat Autònoma de Barcelona (UAB), CEXS-Universitat Pompeu Fabra, Barcelona, Spain.
Hospital Erasto Gaertner. Departamento de Doenças Infecciosas. Curitiba, PR, Brasil.
Spanish Network for Research in Infectious Diseases (REIPI), Instituto de Salud Carlos III, Madrid, Spain / Emergency Clinical Unit, Hospital Universitario Virgen Macarena. Sevilla, Spain.
Haematology Department, Son Espases University Hospital. Palma de Mallorca, Spain.
Unit of Infectious and Tropical Diseases, IRCCS San Raffaele Scientific Institute. Milan, Italy.
Infectious Diseases Clinic, Department of Medicine, University of Udine and Azienda Sanitaria Universitaria Integrata. Udine, Italy.
Infectious Diseases and Microbiology Unit, Navarra University Clinic. Pamplona, Spain.
Spanish Network for Research in Infectious Diseases (REIPI), Instituto de Salud Carlos III, Madrid, Spain / Infectious Diseases Department, Hospital Clinic i Provincial de Barcelona. Barcelona, Spain
2Spanish Network for Research in Infectious Diseases (REIPI), Instituto de Salud Carlos III, Madrid, Spain / Infectious Diseases Department, Vall d'Hebron University Hospital. Barcelona, Spain.
Ege University. Faculty of Medicine. Izmir, Turkey.
University Hospitals Plymouth NHS Trust. Microbiology Department. UK.
Haematology Department, Marques de Valdecilla University Hospital. Santander, Spain.
Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Rio de Janeiro, RJ, Brasil / Ministério da Saúde. Hospital Federal Servidores do Estado. Rio de Janeiro, RJ, Brasil.
Infectious Diseases Department. Bellvitge University Hospital. IDIBELL. University of Barcelona. Barcelona, Spain / Spanish Network for Research in Infectious Diseases (REIPI). Instituto de Salud Carlos III. Madrid, Spain.
Infectious Diseases Department. Bellvitge University Hospital. IDIBELL. University of Barcelona. Barcelona, Spain / Spanish Network for Research in Infectious Diseases (REIPI). Instituto de Salud Carlos III. Madrid, Spain.
Haematology Department, Institut Català d' Oncologia (ICO). Hospital Duran i Reynals, IDIBELL, Barcelona, Spain.
Statistics Advisory Service, Institute of Biomedical Research of Bellvitge, Rovira i Virgili University. Barcelona, Spain.
Infectious Diseases Department, Hacettepe University School of Medicine. Ankara, Turkey.
Infectious Diseases Department, Instituto de Ciencias e Innovación en Medicina, Facultad de Medicina, Clínica Alemana. Universidad del Desarrollo, Santiago de Chile, Chile.
Infectious Diseases Department. Parc Taulí University Hospital, Sabadell, Barcelona, Spain.
Infectious Diseases Department, Department of Medicine, Lausanne University Hospital (CHUV). Lausanne, Switzerland.
Department of Infectious Diseases and Clinical Microbiology, University of Health Science Izmir Bozyaka Training and Research Hospital, Izmir, Turkey.
Oncohematology Department, Comenius University and National Cancer Institute. Bratislava, Slovakia.
Haematology Department, Reina Sofía University Hospital-IMIBIC-UCO. Córdoba, Spain.
Department of Haematology, Oncology and Palliative Care, Klinikum Ernst von Bergmann, Academic Teaching Hospital of Charité University Medical School, Berlin, Germany.
Centro de Educación Médica e Investigaciones Clínicas (CEMIC). Departament of Medicine, Infectious Disease Section. Buenos Aires, Argentina.
Universidade de São Paulo. Faculdade de Medicina. Instituto do Câncer do Estado de São Paulo. São Paulo, SP, Brasil.
Department of Infectious Diseases and Clinical Microbiology, Istanbul Education and Research Hospital. Istanbul, Turkey.
Infectious Diseases Division. American University of Beirut Medical Center. Beirut, Lebanon.
Division of Infectious Diseases, Department of Medicine II, University of Freiburg, Medical Center and Faculty of Medicine. Freiburg, Germany.
Infectious Diseases Unit, Instituto de Investigación Hospital "12 de Octubre" (i+12), " 12 de Octubre" University Hospital, School of Medicine, Universidad Complutense. Madrid, Spain.
Hospital Rawson. Infectious Diseases. San Juan, Argentina
Infectious Diseases and Clinical Microbiology Department, Clínica Maraya. Pereira, Colombia / Critical Care and Clinical Microbiology Department. Universidad de Manizales. Manizales, Colombia.
Hospital Regional Universitario de Málaga. Infectious Diseases Department. Málaga, Spain.
Ramon y Cajal Hospital, Madrid. Infectious Diseases Department. Madrid, Spain.
University of Genoa (DISSAL) and Ospedale Policlinico San Martino. Division of Infectious Diseases. Genova, Italy.
Spanish Network for Research in Infectious Diseases (REIPI). Instituto de Salud Carlos III. Madrid, Spain / Cruces University Hospital. Infectious Diseases Unit. Bilbao, Spain.
Spanish Network for Research in Infectious Diseases (REIPI). Instituto de Salud Carlos III. Madrid, Spain / Infectious Diseases Service, Hospital del Mar, Infectious Pathology and Antimicrobials Research Group (IPAR), Institut Hospital del Mar d'Investigacions Mèdiques (IMIM), Universitat Autònoma de Barcelona (UAB), CEXS-Universitat Pompeu Fabra, Barcelona, Spain.
Hospital Erasto Gaertner. Departamento de Doenças Infecciosas. Curitiba, PR, Brasil.
Spanish Network for Research in Infectious Diseases (REIPI), Instituto de Salud Carlos III, Madrid, Spain / Emergency Clinical Unit, Hospital Universitario Virgen Macarena. Sevilla, Spain.
Haematology Department, Son Espases University Hospital. Palma de Mallorca, Spain.
Unit of Infectious and Tropical Diseases, IRCCS San Raffaele Scientific Institute. Milan, Italy.
Infectious Diseases Clinic, Department of Medicine, University of Udine and Azienda Sanitaria Universitaria Integrata. Udine, Italy.
Infectious Diseases and Microbiology Unit, Navarra University Clinic. Pamplona, Spain.
Spanish Network for Research in Infectious Diseases (REIPI), Instituto de Salud Carlos III, Madrid, Spain / Infectious Diseases Department, Hospital Clinic i Provincial de Barcelona. Barcelona, Spain
2Spanish Network for Research in Infectious Diseases (REIPI), Instituto de Salud Carlos III, Madrid, Spain / Infectious Diseases Department, Vall d'Hebron University Hospital. Barcelona, Spain.
Ege University. Faculty of Medicine. Izmir, Turkey.
University Hospitals Plymouth NHS Trust. Microbiology Department. UK.
Haematology Department, Marques de Valdecilla University Hospital. Santander, Spain.
Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Rio de Janeiro, RJ, Brasil / Ministério da Saúde. Hospital Federal Servidores do Estado. Rio de Janeiro, RJ, Brasil.
Infectious Diseases Department. Bellvitge University Hospital. IDIBELL. University of Barcelona. Barcelona, Spain / Spanish Network for Research in Infectious Diseases (REIPI). Instituto de Salud Carlos III. Madrid, Spain.
Abstract
Pseudomonas aeruginosa (PA) has historically been one of the major causes of severe sepsis and death among neutropenic cancer patients. There has been a recent increase of multidrug-resistant PA (MDRPA) isolates that may determine a worse prognosis, particularly in immunosuppressed patients. The aim of this study is to establish the impact of antibiotic resistance on the outcome of neutropenic onco-haematological patients with PA bacteraemia, and to identify the risk factors for MDRPA bacteraemia and mortality.
Keywords in Portuguese
Resistência a antibióticosEstudo internacional multicêntrico
Protocolo de estudo
Pacientes com câncer neutropênico
Retrospectiva
Bacteremia por Pseudomonas aeruginosa
Keywords
Antibiotic resistanceNeutropenic cancer patients
Pseudomonas aeruginosa bacteraemia
Study protocol
Multicentre international study
Retrospective
Share